title: Effects of arsenite and UVA-1 radiation on calcineurin signaling.
abstract: Calcineurin is a Ca(2+)-dependent serine/threonine phosphatase and the target of the immunosuppressive drugs cyclosporin and tacrolimus, which are used in transplant recipients to prevent rejection. Unfortunately, the therapeutic use of this drugs is complicated by a high incidence of skin malignancy, which has set off a number of studies into the role of calcineurin signaling in skin, particularly with respect to cell cycle control and DNA repair. Both UVA1 radiation and arsenic species are known to promote skin cancer development via production of reactive oxygen species. In light of the well-documented sensitivity of calcineurin to oxidative stress, we examined and compared the effects of UVA1 and arsenite on calcineurin signaling. In this paper, we show that physiologically relevant doses of UVA1 radiation and low micromolar concentrations of arsenite strongly inhibit calcineurin phosphatase activity in Jurkat and skin cells and decrease NFAT nuclear translocation in Jurkat cells. The effects on calcineurin signaling could be partly prevented by inhibition of NADPH oxidase in Jurkat cells or increased dismutation of superoxide in Jurkat and skin cells. In addition, both UVA1 and arsenite decreased NF-κB activity, although at lower concentrations, arsenite enhanced NF-κB activity. These data indicate that UVA1 and arsenite affect a signal transduction route of growingly acknowledged importance in skin and that calcineurin may serve as a potential link between ROS exposure and impaired tumor suppression.
authors.affiliation: Department of Clinical Chemistry, Leiden University Medical Center, The Netherlands. rm@ream.nl
authors.forename: Ruben E A
authors.initials: RE
authors.lastname: Musson
authors.forename: Leon H F
authors.initials: LH
authors.lastname: Mullenders
authors.forename: Nico P M
authors.initials: NP
authors.lastname: Smit
mesh_terms: D018053:Arsenites / Q000493:pharmacokinetics*; D019703:Calcineurin / Q000378:metabolism* / Q000494:pharmacology*; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D019169:Jurkat Cells; D050778:NFATC Transcription Factors / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects / Q000528:radiation effects; D012867:Skin / Q000187:drug effects* / Q000378:metabolism / Q000528:radiation effects*; D013481:Superoxides / Q000378:metabolism; D051996:Transcription Factor RelA / Q000378:metabolism; D014466:Ultraviolet Rays
chemical_list: D018053:Arsenites; D050778:NFATC Transcription Factors; D051996:Transcription Factor RelA; D013481:Superoxides; D019703:Calcineurin; C015001:arsenite